Phenytoin Correction Calculator
Correct phenytoin levels for albumin and renal function using Winter-Tozer equation. Enter values for instant results with step-by-step formulas.
Calculator
Adjust values & calculateFormula
The Winter-Tozer equation adjusts the measured total phenytoin level for hypoalbuminemia. The denominator (0.2 x Albumin + 0.1) represents the expected protein binding fraction. For dialysis patients, the coefficient changes to 0.1 to account for uremic displacement from binding sites. Normal albumin is 3.5-5.0 g/dL; at normal albumin of 4.4, the denominator equals approximately 1.0 and no correction occurs.
Last reviewed: January 2026
Worked Examples
Example 1: Standard Albumin Correction
Example 2: Dialysis Patient Correction
Background & Theory
The Phenytoin Correction Calculator applies the following established principles and formulas. Health and medicine calculators are grounded in validated physiological measurement methods established through decades of clinical research. Body Mass Index, or BMI, is calculated by dividing weight in kilograms by height in meters squared (kg/m²), a formula originating from Adolphe Quetelet's 19th-century statistical work and later codified by the WHO into standard classifications: underweight below 18.5, normal weight 18.5 to 24.9, overweight 25 to 29.9, and obese at 30 and above. Basal Metabolic Rate quantifies the minimum energy required to sustain life at rest. The Mifflin-St Jeor equation, published in 1990 and widely regarded as the most accurate for most adults, calculates BMR as (10 × weight in kg) + (6.25 × height in cm) − (5 × age) ± sex adjustment. The older Harris-Benedict equations, revised in 1984 by Roza and Shizgal, remain in common use. Total Daily Energy Expenditure is derived by multiplying BMR by a physical activity factor ranging from 1.2 for sedentary individuals to 1.9 for extremely active ones, following the methodology validated by doubly labeled water studies. Body fat percentage can be estimated without laboratory equipment using the U.S. Navy circumference method, which uses neck, waist, and hip measurements, or via BMI-derived equations adjusted for age and sex. The Jackson-Pollock skinfold method offers higher precision with calipers. Blood pressure classification, according to the American College of Cardiology and the 2017 ACC/AHA guidelines, defines normal as below 120/80 mmHg, elevated as 120 to 129 systolic, and hypertension stage 1 as 130 to 139 systolic or 80 to 89 diastolic. Target heart rate zones for aerobic exercise are derived from maximum heart rate estimates, most commonly using the formula 220 minus age in years, with moderate-intensity training typically defined as 50 to 70 percent of maximum heart rate and vigorous intensity at 70 to 85 percent, consistent with CDC and American Heart Association guidelines. These thresholds guide safe and effective cardiovascular conditioning.
History
The history behind the Phenytoin Correction Calculator traces back through the following developments. The history of health measurement stretches back to ancient Greece, where Hippocrates around 400 BCE laid the foundation for observational medicine by systematically recording patient symptoms, diet, and environment. His humoral theory, though scientifically superseded, established the principle that the body operates as an interconnected system subject to measurable imbalance. The transformation toward modern medicine accelerated in the 19th century. Louis Pasteur and Robert Koch developed germ theory in the 1860s and 1870s, identifying microorganisms as disease agents and enabling targeted interventions. Florence Nightingale, working during the Crimean War in the 1850s, introduced statistical analysis to nursing practice, demonstrating through data visualization that sanitation reduced mortality. Her work is foundational to evidence-based health measurement. The discovery of vitamins in the early 20th century, beginning with Casimir Funk's coinage of the term in 1912 and culminating in the isolation of vitamins A through K, created the field of nutritional science and gave rise to dietary reference intake frameworks. The World Health Organization, founded in 1948, subsequently established global standards for health metrics, disease classification through the International Classification of Diseases, and recommended daily allowances. The BMI as a clinical screening tool gained traction in the 1970s through Ancel Keys' large-scale epidemiological work, which validated Quetelet's index as a population-level obesity indicator. Through the 1980s and 1990s, the Framingham Heart Study produced landmark data linking cholesterol, blood pressure, and lifestyle factors to cardiovascular disease risk, directly shaping the numeric thresholds still used in health calculators. The evidence-based medicine movement, formalized by Gordon Guyatt and colleagues at McMaster University in the early 1990s, demanded that all health recommendations derive from systematically graded clinical evidence. The digital health era beginning in the 2000s brought these formulas to consumer devices, wearable sensors, and smartphone applications, expanding access to health self-monitoring on a global scale and enabling population-level data collection that continues to refine clinical reference ranges.
Frequently Asked Questions
Formula
Corrected Phenytoin = Measured Level / (0.2 x Albumin + 0.1)
The Winter-Tozer equation adjusts the measured total phenytoin level for hypoalbuminemia. The denominator (0.2 x Albumin + 0.1) represents the expected protein binding fraction. For dialysis patients, the coefficient changes to 0.1 to account for uremic displacement from binding sites. Normal albumin is 3.5-5.0 g/dL; at normal albumin of 4.4, the denominator equals approximately 1.0 and no correction occurs.
Worked Examples
Example 1: Standard Albumin Correction
Problem: A patient has a measured phenytoin level of 7.2 mcg/mL and albumin of 2.0 g/dL. Normal renal function. Is the corrected level therapeutic?
Solution: Winter-Tozer: Corrected = Measured / (0.2 x Albumin + 0.1)\nCorrected = 7.2 / (0.2 x 2.0 + 0.1)\nCorrected = 7.2 / (0.4 + 0.1)\nCorrected = 7.2 / 0.5\nCorrected = 14.4 mcg/mL\nTherapeutic range: 10-20 mcg/mL
Result: Corrected level: 14.4 mcg/mL (therapeutic) - no dose change needed
Example 2: Dialysis Patient Correction
Problem: A hemodialysis patient has measured phenytoin of 5.0 mcg/mL and albumin of 2.8 g/dL. Calculate the corrected level.
Solution: Modified equation for dialysis: Corrected = Measured / (0.1 x Albumin + 0.1)\nCorrected = 5.0 / (0.1 x 2.8 + 0.1)\nCorrected = 5.0 / (0.28 + 0.1)\nCorrected = 5.0 / 0.38\nCorrected = 13.2 mcg/mL\nTherapeutic range: 10-20 mcg/mL
Result: Corrected level: 13.2 mcg/mL (therapeutic) - dialysis correction reveals adequate level
Frequently Asked Questions
How does hypoalbuminemia affect phenytoin levels?
Phenytoin is approximately 90 percent bound to plasma proteins, predominantly albumin, with only the remaining 10 percent being free and pharmacologically active. When albumin levels decrease below the normal range of 3.5 to 5.0 g/dL, fewer binding sites are available, causing a larger fraction of phenytoin to circulate in its unbound active form. This means a patient with low albumin may have a total phenytoin level that appears subtherapeutic at 6 mcg/mL, but after correction for albumin of 2.0 g/dL, the adjusted level could be 12 mcg/mL, which is well within the therapeutic range. Without this correction, clinicians might inappropriately increase the dose and cause toxicity.
How does renal impairment affect phenytoin binding?
Patients with significant renal impairment, particularly those with creatinine clearance below 10 to 20 mL/min or those on hemodialysis, have altered phenytoin protein binding due to the accumulation of uremic toxins that compete with phenytoin for albumin binding sites. This results in a higher free fraction of phenytoin even if albumin levels are normal. The modified Winter-Tozer equation for renal patients uses a different coefficient: Corrected Phenytoin = Measured / (0.1 x Albumin + 0.1) for dialysis patients. This accounts for the additional displacement of phenytoin from albumin by uremic compounds. Whenever possible, free phenytoin levels should be measured directly in renal patients for the most accurate assessment.
What is the therapeutic range for phenytoin?
The standard therapeutic range for total phenytoin is 10 to 20 mcg/mL, while the free phenytoin therapeutic range is 1.0 to 2.0 mcg/mL. Some neurologists accept a slightly wider range of 10 to 20 mcg/mL for seizure prophylaxis and 15 to 20 mcg/mL for active seizure management. Toxicity symptoms typically begin above 20 mcg/mL with nystagmus, progress to ataxia above 30 mcg/mL, and can include lethargy and coma above 40 mcg/mL. The free level is the better predictor of both efficacy and toxicity since it represents the active drug fraction. It is important to note that some patients may have adequate seizure control at levels below the standard therapeutic range.
When should free phenytoin levels be ordered instead of total levels?
Free phenytoin levels should be ordered in any clinical situation where protein binding may be altered, making total levels unreliable. This includes patients with hypoalbuminemia below 3.5 g/dL, renal failure with creatinine clearance below 20 mL/min, hepatic dysfunction with impaired albumin synthesis, pregnancy where albumin dilution occurs, critically ill patients in the ICU with multiple binding alterations, and patients taking medications that displace phenytoin from albumin such as valproic acid. Free levels are the gold standard measurement but are more expensive and take longer to result than total levels. When free levels are unavailable, the Winter-Tozer correction provides a reasonable estimate.
How does valproic acid interact with phenytoin binding?
Valproic acid is one of the most clinically significant drugs that interact with phenytoin protein binding. Valproic acid competes with phenytoin for albumin binding sites, displacing phenytoin and increasing its free fraction from the normal 10 percent to as high as 15 to 20 percent. This displacement means that total phenytoin levels may decrease or appear low while free levels remain therapeutic or even become toxic. The standard Winter-Tozer equation does not account for this interaction, and patients on concurrent valproic acid should have free phenytoin levels monitored directly. Additionally, valproic acid inhibits phenytoin metabolism through CYP2C9, adding a pharmacokinetic interaction on top of the binding displacement.
How should phenytoin doses be adjusted based on corrected levels?
Phenytoin dose adjustments must account for its nonlinear (Michaelis-Menten) pharmacokinetics, where small dose changes can produce disproportionately large changes in serum levels near saturation. If the corrected level is subtherapeutic, doses should be increased cautiously, typically by no more than 30 to 50 mg per day for maintenance dosing. If supratherapeutic, the dose should be held until levels decrease and then restarted at a lower maintenance dose. Loading doses can be given for acutely subtherapeutic patients using the formula: Loading Dose = (Target - Current Corrected Level) x Volume of Distribution x Weight. The volume of distribution for phenytoin is approximately 0.7 L/kg. Levels should be rechecked 5 to 7 days after dose changes to allow for steady state.
References
Reviewed by Rahul Singh, Health & Wellness Specialist · Editorial policy